<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230828059290N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-09-12</date_registration>
      <primary_sponsor>Khoram-Abad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of sports activity on bones</public_title>
      <acronym></acronym>
      <scientific_title>The effect of 12 weeks of resistance training with different muscle tensions on mir-92, mir-204, mir-214, mir-233 and sclerostin in elderly women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>15</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/72316</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: It is block randomization. In order to perform block randomization, a specific code is assigned to each of the people under study (66 people). Then, blocks with a volume of 6 people, which have 3 exclusive codes, are defined. Two A codes, two B codes, and two C codes are identified. Each of these three codes represent each of the groups under study. From the combination and sequence of these codes in blocks of 6, different blocks are created. Then, using Stata software version 17 and using the command code egen block, blocks of 6 are selected by simple random method with placement. 11 blocks are selected using simple random placement method.</study_design>
      <phase>N/A</phase>
      <hc_freetext>The subject of study is not a disease.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Intervention group: In this research, according to the training protocol, there are two intervention groups. In the first group, the resistance training protocol is in the form of three periods of 12 repetitions with 75% of a maximum repetition and with two-minute rests between periods, with a duration of one second of muscle tension. (one second of flexion and one second of extension) and in the second group in the form of three periods of three repetitions with 50% of a maximum repetition and with two-minute rests between periods, with a duration of six seconds of muscle tension (six seconds of flexion and six seconds of extension). Was performed. Intervention 2: Control group: Control group: In this research, there is a control group and they will not do any regular physical activity or exercise during the implementation of the protocol.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The information is confidential and the results will be published as an article

When:
It does not have a specific yield

To whom:
Only the research team is allowed to access the data

Conditions:
It is for the purpose of analyzing information.

Where to obtain:
The documents are only available to the research team

How to obtain:
The documents are only available to the research team

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fazlollah Fathollahi Shoorabeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kilometer 4, Borujerd Road, Medical Sciences Complex, Faculty of Medicine</address>
        <city>Khormabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1478523698</zip>
        <telephone>+98 66 3342 5492</telephone>
        <email>f.fathollahi1363@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fazlollah Fathollahi Shorabeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kilometer 4, Borujerd Road, Medical Sciences Complex, Faculty of Medicine</address>
        <city>Khoramabad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1478523695</zip>
        <telephone>+98 66 3342 5492</telephone>
        <email>f.fathollahi1363@gmail.com</email>
        <affiliation>Khoram-Abad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>No surgery
Not having any heart disease
Not smoking and drinking alcohol
Not having a physical problem such as orthopedic and brain-nervous problems that prevent exercise.
Blood pressure &gt; 110/180 as a criterion for exiting the study process
Menopause
Age range in the specified age range of 45 to 65</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Lack of continuous exercise before starting the training program
Inability to exercise</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>ICD-10</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Diagnosis</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Intervention group: In this research, according to the training protocol, there are two intervention groups. In the first group, the resistance training protocol is in the form of three periods of 12 repetitions with 75% of a maximum repetition and with two-minute rests between periods, with a duration of one second of muscle tension. (one second of flexion and one second of extension) and in the second group in the form of three periods of three repetitions with 50% of a maximum repetition and with two-minute rests between periods, with a duration of six seconds of muscle tension (six seconds of flexion and six seconds of extension). Was performed.</i_keyword>
      <i_keyword>Control group: Control group: In this research, there is a control group and they will not do any regular physical activity or exercise during the implementation of the protocol.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Increased serum sclerostin levels. Timepoint: 48 hours before and after the last training session. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Decreased serum mir-92 levels. Timepoint: 48 hours before and after the last training session. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Increased serum mir-214 levels. Timepoint: 48 hours before and after the last training session. Method of measurement: blood test.</prim_outcome>
      <prim_outcome>Decreased serum mir-233 levels. Timepoint: 48 hours before and after the last training session. Method of measurement: blood test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Noblood pressure. Timepoint: 48 hours before and after the implementation of the research protocol. Method of measurement: nothrough a blood pressure monitor.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khoram-Abad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-09</approval_date>
        <contact_name>Research Ethics Committees of Lorestan University of Medical Sciences</contact_name>
        <contact_address>km 4, Borujerd Road, Vice-Chancellor of Research and Technology, Lorestan University of Medical Sciences Khorram Abad Lorestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
